亚辉龙（688575）8月15日主力资金净流出1229.49万元

Group 1 - The core viewpoint of the news is that Shenzhen Yahui Long Biotechnology Co., Ltd. (亚辉龙) has shown a decline in its financial performance for the first quarter of 2025, with total revenue decreasing by 3.13% year-on-year and net profit dropping by 84.63% [1] - As of August 15, 2025, the company's stock price closed at 15.51 yuan, reflecting an increase of 1.44% with a trading volume of 60,500 lots and a transaction amount of 93.5745 million yuan [1] - The company experienced a net outflow of main funds amounting to 12.2949 million yuan, which accounted for 13.14% of the total transaction amount, indicating a significant withdrawal of larger investments [1] Group 2 - The latest financial report indicates that the company's operating revenue for the first quarter of 2025 was 418 million yuan, with a net profit attributable to shareholders of 10.148 million yuan and a non-recurring net profit of 36.9052 million yuan [1] - The company has a current ratio of 2.124, a quick ratio of 1.432, and a debt-to-asset ratio of 37.24%, suggesting a relatively stable liquidity position [1] - Shenzhen Yahui Long has made investments in 21 companies and participated in 680 bidding projects, showcasing its active engagement in the market [2]